$ROG

Rogers Targets $1.5B Sales by 2030 on AI Data Center, Battery Growth

Rogers Corp. aims for $1.5B in sales by 2030, driven by AI data centers and battery systems. The company expects $450M+ annual revenue from adjacencies by 2030, with data centers as the largest opportunity. Rogers targets 13% annual revenue growth, 26% EBITDA margin, and $14 adjusted EPS by 2030. In 2026, it expects $870M sales, up from $811M in 2025, with improved margins and EPS.

Original reporting
Published Oct 3, 2026, 8:02 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 3, 2026, 10:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rogers Targets $1.5B Sales by 2030 on AI Data Center, Battery Growth — source image
Decision brief

The 30-second read

$ROGNeutralLow
01

Why it matters

The article repeats guidance already released, offering little new actionable insight.

02

Market read

Low immediate relevance; serves as a recap of previously disclosed guidance.

03

What to watch

Potential supply‑chain constraints and capital‑intensity of micro‑channel cooling could delay revenue realization.

Relevance 4/10Novelty 2/10Timing: none

Background

Rogers Corp (NYSE:ROG) outlined its 2026 sales forecast and 2030 targets for AI data‑center, battery safety, and EMI shielding markets.

Company-level read

Ticker impact

$ROGNeutralMedium confidence
Context

Company disclosed 2026 guidance and long‑term 2030 sales target of $1.5 B, new revenue mix and margin goals.

Expected impact

potential modest upside as investors price in long‑term growth, but limited by prior disclosure

Evidence & confidence

Guidance was already public weeks ago; the article adds no new data, so any price move would be incremental.

Market effects

Highlights AI‑related data‑center and battery material demand, modestly supportive of engineered‑materials sector.

U.S. industrial and technology investors may note longer‑term growth, but no immediate regional shift.

Limited; reinforces broader AI infrastructure narrative without new catalyst.

Counterpoint

Guidance may be overly optimistic given competitive pressures; investors could stay cautious.

Key entities

  • Rogers Corporation

    US‑listed engineered materials manufacturer.

Related articles

$ROGHighAI 9/10

‘Rogers Sports,’ Housing Radio/TV Assets, Coming With Pelley At Helm

Rogers Communications Inc. completed its acquisition of the remaining 25% stake in Maple Leaf Sports & Entertainment (MLSE) for $4.35 billion CAD. The company will form a new unit, Rogers Sports, to manage its media assets, with Keith Pelley leading it. Pelley will also oversee Rogers Media, succeeding Colette Watson, who is retiring.

$ROGHighAI 9/10

Rogers completes takeover of remaining 25% of MLSE

Rogers Communications completed its acquisition of the remaining 25% stake in Maple Leaf Sports & Entertainment (MLSE) from Kilmer Sports for $4.35 billion. The deal unites Toronto's major sports teams under Rogers' ownership, including the Maple Leafs, Raptors, and Blue Jays, along with related assets. Rogers plans to monetize its sports and media assets, valued at over $25 billion, by selling minority stakes by mid-2027 to reduce debt.

$ROGHighAI 8/10

Rogers (ROG) Shares Skyrocket, What You Need To Know

Rogers (ROG) shares rose 17% after an Investor Day where management set 2030 targets, including 13% revenue CAGR, 26% EBITDA margin, and $14.00 adjusted EPS. The company reported Q3 2025 revenue of $216M, up 2.7%, and beat EPS estimates by 30%. Rogers is up 70.6% YTD, trading near its 52-week high.

$MRNAHighAI 8/10

Why Moderna's Cancer Vaccine Matters To Investors

Moderna (MRNA) and Merck (MRK) reported successful late-stage trial results for a personalized mRNA cancer vaccine targeting melanoma, reducing recurrence risk by 49%. The treatment relies on technologies from Illumina (ILMN), Danaher (DHR), and others. Moderna's stock surged 176.97% on the news, highlighting the shift toward individualized therapies in oncology.

$ROGMedAI 8/10

Why is Rogers stock rallying today? By Investing.com

Rogers stock rose about 3.5% in pre-open after its Q2 2026 results beat expectations, with adjusted EPS of $0.92 on revenue of $216.8 million versus $0.79 and $210.9 million. The company guided Q3 EPS of $1.10–$1.30 and revenue of $233–$243 million. The move follows a prior selloff tied to supply chain headwinds and a plant fire.

$ROGHigh

Rogers Corporation Reports Second Quarter 2026 Results

ROGERS CORP (ROG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026resultsannouncement.htm EX-99.1 Document Rogers Corporation Reports Second Quarter 2026 Results • Net sales of $216.8 million increased 6.9% year-over-year (YoY) • Gross margin of 32.5% increased 90 basis points YoY • Net income of $13.6 million, versus a $73.6 mi